Ashwagandha for Skin and Hair: Exploring Potential Topical Uses in Midlife
Ashwagandha’s skin and hair claims rest largely on cortisol, antioxidant and traditional topical use. What is evidenced and what is marketing.
Ashwagandha’s skin and hair claims rest largely on cortisol, antioxidant and traditional topical use. What is evidenced and what is marketing.
Ashwagandha supports energy by lowering cortisol load rather than by stimulating. Why it feels different from caffeine, and what to expect in perimenopause.
Ashwagandha may lower blood glucose enough to matter alongside metformin or insulin. What perimenopausal women managing blood sugar should know first.
Ashwagandha root powder and full-spectrum extract are not interchangeable at the same milligram dose. How concentration ratios change your real intake.
Stress resilience is a measurable adaptation, not a mood. How ashwagandha’s cortisol and perceived stress data map onto the demands of midlife.
Ashwagandha is a root, not a food crop, so dietary sources are effectively limited to preparations of the plant itself. What that means in practice.
Magnesium works on the GABA and NMDA pathway, ashwagandha on cortisol. Which one fits perimenopausal insomnia depends on why you are waking up.
Documented ashwagandha liver injury cases exist and are rare but real. What the case reports actually describe, and the warning signs worth knowing.
Ashwagandha trials in active adults show gains in VO2 max, strength and recovery markers. How much of that is likely to transfer to perimenopausal training.
Ashwagandha and alcohol share sedative pathways and both load the liver. Why the combination raises drowsiness and hepatic risk more than either alone.
Gastrointestinal upset is the most reported ashwagandha side effect in women, and it is dose-linked. What else shows up, and when it means stopping.
Perimenopausal fatigue has several drivers and cortisol is only one. Where ashwagandha’s stamina and VO2 max data is genuinely suggestive, and where it is thin.